Jian Li

L. Shen, Zhi Peng, Siyuan Cheng, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Using genotype to assist clinical surveillance: a retrospective study of Chinese familial adenomatous polyposis patients.

Jian Li, Xicheng Wang, S. Ge, 2022, American journal of cancer research.

Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.

L. Shen, Jian Li, Jing Gao, 2018, Future oncology.

Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma

Zhi Peng, Xiaotian Zhang, Jian Li, 2022, Frontiers in Oncology.

A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor.

L. Shen, Xiaoyan Chen, D. Zhong, 2021, Journal of separation science.

A validated Ultra HPLC-MS/MS method for determination of TQ-B3203 in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor.

Jian Li, Jun Zhou, Fen Yang, 2020, Journal of separation science.

Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study

L. Shen, Xiaotian Zhang, J. Gong, 2019, Journal of Cancer.

Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first‐line chemotherapy

L. Shen, Xiaotian Zhang, J. Gong, 2016, Cancer medicine.

Early change in peripheral CD4+ T cells associated with clinical outcomes of immunotherapy in gastrointestinal cancer.

L. Shen, Xiaotian Zhang, Jian Li, 2020, Immunotherapy.

Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study

Jun Zhang, L. Shen, Jian Li, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase II study of triweekly paclitaxel and capecitabine combination therapy in patients with fluoropyrimidine-platinum-resistant metastatic gastric adenocarcinoma.

L. Shen, J. Gong, Jian Li, 2013, Journal of Cancer Research and Therapeutics.

Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial

L. Shen, Lili Tang, Yi He, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The patterns and timing of recurrence after curative resection for gastric cancer in China

Zhen Zhang, L. Shen, Q. Feng, 2016, World Journal of Surgical Oncology.

Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma.

B. Xing, L. Shen, Jian Li, 2017, Radiology.

Regorafenib, TAS-102, or fruquintinib for metastatic colorectal cancer: any difference in randomized trials?

L. Shen, Zhi Peng, Jian Li, 2019, International Journal of Colorectal Disease.

Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer

Xiaotian Zhang, Jian Li, Xicheng Wang, 2023, Cancer medicine.

CACA guidelines for holistic integrative management of rectal cancer

Yaoping Li, J. Gu, Ye Xu, 2023, Holistic Integrative Oncology.

Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial

L. Shen, Xiaotian Zhang, J. Gong, 2016, Cancer science.

Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis

L. Shen, Jinyu Yu, Zhi Peng, 2021, Frontiers in Pharmacology.

Pyrotinib alone or in combination with docetaxel in refractory HER2‐positive gastric cancer: A dose‐escalation phase I study

R. Xu, Xiaotian Zhang, J. Gong, 2023, Cancer medicine.

Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma

Jun Yu Li, M. Shi, J. Gong, 2023, Cancer Immunology, Immunotherapy.

Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis

Xiaotian Zhang, J. Gong, Jian Li, 2022, Cancer research and treatment.

Survival Benefit of Palliative Local Treatments and Efficacy of Different Pharmacotherapies in Colorectal Cancer With Lung Metastasis: Results From a Large Retrospective Study

L. Shen, Xiaotian Zhang, Jian Li, 2017, Clinical colorectal cancer.

Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review

L. Shen, Zhi Peng, Jian Li, 2021, Hereditary cancer in clinical practice.

Clinical trial analysis of 2019‐nCoV therapy registered in China

L. Shen, Jian Li, Yakun Wang, 2020, Journal of medical virology.

Multi-omics of the gut microbial ecosystem in the immunotherapy resistance in microsatellite instability-high gastrointestinal cancer patients

Jun Zhou, Jian Li, Zhi Peng, 2023, bioRxiv.

Response to “Comments on 'Zhang et al: Clinical trial analysis of 2019‐nCoV therapy registered in China'”

L. Shen, Jian Li, Yakun Wang, 2020, Journal of medical virology.

Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer

L. Shen, Yujiao Wang, Zhi Peng, 2021, Cancer biology & medicine.

Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study

K. Tao, Jun Zhang, Jian Li, 2022, The oncologist.

Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment

Zhi Peng, Xiaotian Zhang, Jian Li, 2022, BMC cancer.

Heterogeneity of metastatic gastrointestinal stromal tumor on texture analysis: DWI texture as potential biomarker of overall survival.

D. Dong, Jie Tian, M. Fang, 2020, European journal of radiology.

Could computed tomography be used as a surrogate of endoscopic ultrasonography in the screening and surveillance of small gastric Gastrointestinal stromal tumors?

Lei Tang, Yingshi Sun, N. Hong, 2020, European journal of radiology.

Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients.

L. Shen, J. Gong, Jian Li, 2012, World journal of gastroenterology.

Use of Radiomics to Predict Response to Immunotherapy of Malignant Tumors of the Digestive System

L. Shen, Hai-Tao Zhu, Yingshi Sun, 2020, Medical science monitor : international medical journal of experimental and clinical research.

Efficacy and safety of sunitinib in Chinese patients with imatinib-resistant or -intolerant gastrointestinal stromal tumors.

L. Shen, Jian Li, Jing Gao, 2012, Future oncology.

PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study

Z. Chang, W. Fang, T. Deng, 2023, JCO precision oncology.

Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study.

L. Shen, Ming-ming Nie, Jian Li, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.

L. Shen, Jian Li, Jing Gao, 2019, Cancer letters.

HER2 Expression in Circulating Tumor Cells as Prognostic and Predictive Biomarkers for Anti‐HER2 Therapy in Previously Treated Metastatic Colorectal Cancer

Ping Li, Jian Li, Xicheng Wang, 2023, Advanced Therapeutics.

Advances in KRAS mutation inhibition in metastatic colorectal cancer

Qi Zhang, Jian Li, T. Bekaii-Saab, 2023, Holistic Integrative Oncology.

Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy

Jian Li, Lin-zhong Zhu, Xiaodong Wang, 2018, World journal of gastrointestinal oncology.

[Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].

L. Shen, Jian Li, Jing Gao, 2013, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts

Xiaotian Zhang, Jian Li, S. Ge, 2023, Advanced science.

Efficacy and Safety Comparison of Regorafenib and Fruquintinib in Metastatic Colorectal Cancer-An Observational Cohort Study in the Real World.

Junyan Zhang, L. Shen, Zhi Peng, 2022, Clinical colorectal cancer.

MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: a patient-based multi-parameter study

J. Ji, L. Shen, Lei Tang, 2018, BMC Cancer.

A phase 2 study of tislelizumab monotherapy in patients with previously treated, locally advanced unresectable ormetastatic microsatellite instability-high/mismatch repair deficient solid tumors.

Jianming Xu, Ye Xu, Dong Wang, 2021, Journal of Clinical Oncology.

Multidimensional immune profiling in Gastric Cancer Multiplex Immunohistochemistry Atlas from Peking University Cancer Hospital project informs PD-1/PD-L1 blockade efficacy.

Xiaotian Zhang, J. Gong, Jian Li, 2023, European journal of cancer.

Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.

Weijian Guo, L. Shen, Jian Li, 2020 .

[Mutation profiles of c-kit/PDGFRα and its associations with clinicopathological characteristics in Chinese gastrointestinal stromal tumors: analysis of 827 cases].

L. Shen, Jian Li, Jing Gao, 2015, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

Phase 1 study of WNT pathway Porcupine inhibitor CGX1321 and phase 1b study of CGX1321 + pembrolizumab (pembro) in patients (pts) with advanced gastrointestinal (GI) tumors.

K. Papadopoulos, M. Pishvaian, A. Dorr, 2023, Journal of Clinical Oncology.

Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors

L. Shen, J. Gong, Jian Li, 2016, Oncotarget.

Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients.

Youping Deng, L. Shen, Shujun Liu, 2021, Cancer letters.

Advanced prompting as a catalyst: Empowering large language models in the management of gastrointestinal cancers

Li Zhang, Jie Zhao, Xiaotian Zhang, 2023, The Innovation Medicine.

Post-operative imatinib in patients with intermediate or high risk gastrointestinal stromal tumor.

J. Gong, Jian Li, L. Shen, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prognostic value of inflammation-based markers in advanced or metastatic neuroendocrine tumours.

Jian Li, Ming Lu, Zhihao Lu, 2019, Current oncology.

Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer

L. Shen, Yujiao Wang, Zhi Peng, 2021, Genome Medicine.

Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer

Xiaotian Zhang, J. Gong, Jian Li, 2022, BMC Medicine.

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

Zhi Peng, J. Gong, Jian Li, 2023, Frontiers in oncology.

CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer

Xiaotian Zhang, J. Gong, Jian Li, 2023, Journal of Hematology & Oncology.

A comparative study between Embosphere(®) and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST.

L. Shen, Jian Li, Lin-zhong Zhu, 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.